JNK pathway in osteosarcoma: pathogenesis and therapeutics

References

• Miao J, Wu S, Peng Z, et al. MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects. Tumour Biol 2013;34:2093–8
   PubMed Web of Science ®Google Scholar
• Sanchez-Diaz PC, Hsiao TH, Zou Y, et al. In silico functional analyses and discovery of survival-associated microRNA signatures in pediatric osteosarcoma. Oncoscience 2014;1:599–608
   PubMedGoogle Scholar
• Moore DD, Luu HH. Osteosarcoma. Cancer Treat Res 2014;162:65–92
   PubMedGoogle Scholar
• Li YS, Deng ZH, Zeng C, Lei GH. Role of osteopontin in osteosarcoma. Med Oncol 2015;32:449
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang L, Zhang G, et al. Osteosarcoma metastasis: prospective role of ezrin. Tumour Biol 2014;35:5055–9
   PubMed Web of Science ®Google Scholar
• Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res 2009;152:3–13
   PubMedGoogle Scholar
• Calvert GT, Randall RL, Jones KB, et al. At-risk populations for osteosarcoma: the syndromes and beyond. Sarcoma 2012;2012:152382
   PubMedGoogle Scholar
• Ferguson WS, Goorin AM. Current treatment of osteosarcoma. Cancer Invest 2001;19:292–315
   PubMed Web of Science ®Google Scholar
• Choeyprasert W, Pakakasama S, Sirachainan N, et al. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience. Asian Pac J Cancer Prev 2014;15:9823–9
   PubMedGoogle Scholar
• Harting MT, Blakely ML. Management of osteosarcoma pulmonary metastases. Semin Pediatr Surg 2006;15:25–9
   PubMedGoogle Scholar
• Tournier C. The 2 faces of JNK signaling in cancer. Genes Cancer 2013;4:397–400
   PubMedGoogle Scholar
• Liu J, Lin A. Role of JNK activation in apoptosis: a double-edged sword. Cell Res 2005;15:36–42
   PubMed Web of Science ®Google Scholar
• Bode AM, Dong Z. The functional contrariety of JNK. Mol Carcinog 2007;46:591–8
   PubMed Web of Science ®Google Scholar
• Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000;103:239–52
   PubMed Web of Science ®Google Scholar
• Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009;9:537–49
   PubMed Web of Science ®Google Scholar
• Fleming Y, Armstrong CG, Morrice N, et al. Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7. Biochem J 2000;352:145–54
   PubMed Web of Science ®Google Scholar
• Bubici C, Papa S. JNK signalling in cancer: in need of new, smarter therapeutic targets. Br J Pharmacol 2014;171:24–37
   PubMed Web of Science ®Google Scholar
• Cuenda A, Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 2007;1773:1358–75
   PubMed Web of Science ®Google Scholar
• Chang L, Kamata H, Solinas G, et al. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 2006;124:601–13
   PubMed Web of Science ®Google Scholar
• Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Genet Dev 2002;12:14–21
   PubMed Web of Science ®Google Scholar
• Karin M, Gallagher E. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance. IUBMB Life 2005;57:283–95
   PubMed Web of Science ®Google Scholar
• Das M, Garlick DS, Greiner DL, Davis RJ. The role of JNK in the development of hepatocellular carcinoma. Genes Dev 2011;25:634–45
   PubMed Web of Science ®Google Scholar
• Messoussi A, Feneyrolles C, Bros A, et al. Recent progress in the design, study, and development of c-Jun N-terminal kinase inhibitors as anticancer agents. Chem Biol 2014;21:1433–43
   PubMed Web of Science ®Google Scholar
• Enomoto M, Kizawa D, Ohsawa S, Igaki T. JNK signaling is converted from anti- to pro-tumor pathway by Ras-mediated switch of Warts activity. Dev Biol 2015;403:162–71
   PubMed Web of Science ®Google Scholar
• Zhang JY, Selim MA. The role of the c-Jun N-terminal kinase signaling pathway in skin cancer. Am J Cancer Res 2012;2:691–8
   PubMed Web of Science ®Google Scholar
• Chen F. JNK-induced apoptosis, compensatory growth and cancer stem cells. Cancer Res 2012;72:379–86
   PubMed Web of Science ®Google Scholar
• Dhanasekaran DN, Reddy EP. JNK signaling in apoptosis. Oncogene 2008;27:6245–51
   PubMed Web of Science ®Google Scholar
• Li GD, Cai ZD, Zhang YQ, et al. [Gene profiling of MAPK pathway in human osteosarcoma]. Zhonghua Zhong Liu Za Zhi 2009;31:340–5
   PubMedGoogle Scholar
• Papachristou DJ, Batistatou A, Sykiotis GP, et al. Activation of the JNK-AP-1 signal transduction pathway is associated with pathogenesis and progression of human osteosarcomas. Bone 2003;32:364–71
   PubMed Web of Science ®Google Scholar
• Kimura R, Ishikawa C, Rokkaku T, et al. Phosphorylated c-Jun and Fra-1 induce matrix metalloproteinase-1 and thereby regulate invasion activity of 143B osteosarcoma cells. Biochim Biophys Acta 2011;1813:1543–53
   PubMed Web of Science ®Google Scholar
• Wang F, Ke ZF, Wang R, et al. Astrocyte elevated gene-1 (AEG-1) promotes osteosarcoma cell invasion through the JNK/c-Jun/MMP-2 pathway. Biochem Biophys Res Commun 2014;452:933–9
   PubMed Web of Science ®Google Scholar
• Chen HJ, Lin CM, Lee CY, et al. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells. Oncol Rep 2013;30:925–32
   PubMed Web of Science ®Google Scholar
• Liang W, Gao B, Xu G, et al. Possible contribution of aminopeptidase N (APN/CD13) to migration and invasion of human osteosarcoma cell lines. Int J Oncol 2014;45:2475–85
   PubMed Web of Science ®Google Scholar
• Alper M, Kockar F. IL-6 upregulates a disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAMTS-2) in human osteosarcoma cells mediated by JNK pathway. Mol Cell Biochem 2014;393:165–75
   PubMed Web of Science ®Google Scholar
• Pan W, Wang H, Jianwei R, Ye Z. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells. Cell Physiol Biochem 2014;33:402–12
   PubMed Web of Science ®Google Scholar
• Chen J, Fu H, Wang Z, et al. A new synthetic ursolic acid derivative IUA with anti-tumor efficacy against osteosarcoma cells via inhibition of JNK signaling pathway. Cell Physiol Biochem 2014;34:724–33
   PubMed Web of Science ®Google Scholar
• Liao CL, Lin JH, Lien JC, et al. The crude extract of Corni fructus inhibits the migration and invasion of U-2 OS human osteosarcoma cells through the inhibition of matrix metalloproteinase-2/-9 by MAPK signaling. Environ Toxicol 2015;30:53–63
   PubMed Web of Science ®Google Scholar
• Liang CZ, Zhang X, Li H, et al. Gallic acid induces the apoptosis of human osteosarcoma cells in vitro and in vivo via the regulation of mitogen-activated protein kinase pathways. Cancer Biother Radiopharm 2012;27:701–10
   PubMed Web of Science ®Google Scholar
• Chueh FS, Chen YY, Huang AC, et al. Bufalin-inhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways. Environ Toxicol 2014;29:21–9
   PubMed Web of Science ®Google Scholar
• Fromigué O, Hamidouche Z, Marie PJ. Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. J Biol Chem 2008;283:30549–56
   PubMed Web of Science ®Google Scholar
• Modrowski D, Orosco A, Thévenard J, et al. Syndecan-2 overexpression induces osteosarcoma cell apoptosis: implication of syndecan-2 cytoplasmic domain and JNK signaling. Bone 2005;37:180–9
   PubMed Web of Science ®Google Scholar
• Yao J, Weng Y, Yan S, et al. NOV inhibits proliferation while promoting apoptosis and migration in osteosarcoma cell lines through p38/MAPK and JNK/MAPK pathways. Oncol Rep 2015;34:2011–21
   PubMed Web of Science ®Google Scholar
• Li HY, Zhang J, Sun LL, et al. Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study. Cell Death Dis 2015;6:e1604
   PubMed Web of Science ®Google Scholar
• Yang F, Nam S, Zhao R, et al. A novel synthetic derivative of the natural product berbamine inhibits cell viability and induces apoptosis of human osteosarcoma cells, associated with activation ofJNK/AP-1 signaling. Cancer Biol Ther 2013;14:1024–31
   PubMed Web of Science ®Google Scholar
• Hou CH, Fong YC, Chen JT, et al. The novel isoflavone 7-hydroxy-3',4'-benzoisoflavone induces cell apoptosis in human osteosarcoma cells. Cancer Lett 2008;271:117–28
   PubMed Web of Science ®Google Scholar
• Zhang TF, Yu SQ, Loggie BW, Wang ZY. Inducible expression of RbAp46 activates c-Jun NH2-terminal kinase-dependent apoptosis and suppresses progressive growth of tumor xenografts in nude mice. Anticancer Res 2003;23:4621–7
   PubMed Web of Science ®Google Scholar
• Lou Z, Ren T, Peng X, et al. Bortezomib induces apoptosis and autophagy in osteosarcoma cells through mitogen-activated protein kinase pathway in vitro. J Int Med Res 2013;41:1505–19
   PubMed Web of Science ®Google Scholar